Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Steroid-refractory Acute Graft Versus Host Disease”

75 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 75 results

Testing effectiveness (Phase 2)Study completedNCT02953678
What this trial is testing

Ruxolitinib in Combination With Corticosteroids for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease (REACH-1)

Who this might be right for
Graft-versus-host Disease (GVHD)
Incyte Corporation 71
Early research (Phase 1)Study completedNCT03327857
What this trial is testing

Neihulizumab (ALTB-168) in Patients With Steroid-refractory Acute Graft-versus-host Disease or Treatment-refractory Acute Graft-versus-host Disease

Who this might be right for
Steroid-refractory Acute Graft-versus-Host DiseaseTreatment-refractory Acute Graft-versus-Host Disease
AltruBio Inc. 37
Testing effectiveness (Phase 2)Ended earlyNCT02322190
What this trial is testing

Biomarkers in Acute Graft-Versus-Host Disease and Extracorporeal Photopheresis Added to Investigator Chosen Therapies of Steroid Refractory Acute GVHD

Who this might be right for
Chronic Graft vs. Host DiseaseGraft vs Host DiseaseGraft-Versus-Host Disease
National Cancer Institute (NCI) 5
Post-approval studies (Phase 4)Looking for participantsNCT06462469
What this trial is testing

Study of Efficacy and Safety of Ruxolitinib in Patients With Grade II to IV Steroid-refractory Acute Graft vs. Host Disease

Who this might be right for
Steroid-refractory Acute Graft Versus Host Disease
Novartis Pharmaceuticals 36
Testing effectiveness (Phase 2)WithdrawnNCT05333029
What this trial is testing

Extracorporeal Photopheresis and Mesenchymal Stem Cell Infusion for GVHD

Who this might be right for
Graft Versus Host Disease
Molly Gallogly
Testing effectiveness (Phase 2)Ended earlyNCT02993783
What this trial is testing

A Dose-Finding Study of Vedolizumab for Treatment of Steroid-Refractory Acute Intestinal Graft-Versus-Host Disease (GvHD) in Participants Who Have Undergone Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT)

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation
Millennium Pharmaceuticals, Inc. 17
Testing effectiveness (Phase 2)Ended earlyNCT00409695
What this trial is testing

Thymoglobulin (ATG) Dose Finding Study

Who this might be right for
Graft vs Host Disease
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Ended earlyNCT01475162
What this trial is testing

Tocilizumab for Treatment of Steroid Refractory Acute Graft-versus-Host Disease

Who this might be right for
Acute Graft Versus Host Disease
Medical College of Wisconsin 14
Testing effectiveness (Phase 2)Ended earlyNCT00032773
What this trial is testing

Dose-finding Study Using Pentostatin for Injection in the Treatment of Steroid-refractory aGvHD

Who this might be right for
Acute Graft Versus Host Disease
Astex Pharmaceuticals, Inc. 36
Testing effectiveness (Phase 2)UnknownNCT05368181
What this trial is testing

MAP-guided Preemptive Therapy of aGvHD

Who this might be right for
GVHD,AcuteStem Cell Transplant Complications
Sichuan University 56
Large-scale testing (Phase 3)Ended earlyNCT04934670
What this trial is testing

Compare T-Guard vs Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-vs-Host Disease (BMT CTN 2002)

Who this might be right for
Steroid-Refractory Acute Graft Versus Host Disease
Xenikos 12
Early research (Phase 1)WithdrawnNCT05443464
What this trial is testing

Mesenchymal Stem Cells (MSCs) for Steroid Refractory Acute GVHD (SR-aGVHD)

Who this might be right for
GVHD,Acute
Ossium Health, Inc.
Not applicableAvailableNCT04768907
What this trial is testing

Early Access Program With MaaT013 in Steroid-refractory Acute Gastrointestinal Graft Versus Host Disease

Who this might be right for
Acute Graft Versus Host Disease in IntestineSteroid Refractory GVHD
MaaT Pharma
Early research (Phase 1)Ended earlyNCT02436460
What this trial is testing

AbGn-168H in Patients With Steroid Refractory Acute Graft-vs-Host Disease After Donor Stem Cell Transplant

Who this might be right for
Acute Graft Versus Host Disease
AbGenomics B.V Taiwan Branch 4
Testing effectiveness (Phase 2)Study completedNCT00492921
What this trial is testing

High-Dose Cyclophosphamide for Steroid Refractory GVHD

Who this might be right for
Graft Versus Host Disease
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 12
Not applicableStudy completedNCT04687332
What this trial is testing

IA or PE - What is the Best Treatment Option of Steroid Refractory Neurological Autoimmune Diseases

Who this might be right for
Neurological Autoimmune Diseases
University Medical Center Mainz 32
Testing effectiveness (Phase 2)UnknownNCT04971551
What this trial is testing

Jaktinib for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease.

Who this might be right for
Acute Graft-Versus-Host Disease
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 60
Not applicableLooking for participantsNCT06321198
What this trial is testing

A Trial to Evaluate the Safety and Preliminary Efficacy of iMesenchymal Stromal Cells(iMSC) in Subjects With SR-aGVHD

Who this might be right for
Steroid-refractory Acute Graft-versus-host Disease(SR-aGVHD)
Anhui Provincial Hospital 12
Testing effectiveness (Phase 2)Ended earlyNCT04910152
What this trial is testing

Novel BET Inhibitor PLX51107 for Steroid-Refractory Acute GVHD

Who this might be right for
Acute Graft Versus Host DiseaseSteroid Refractory Graft Versus Host Disease
Hannah Choe, MD 2
Large-scale testing (Phase 3)Looking for participantsNCT04629833
What this trial is testing

Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy

Who this might be right for
Steroid-refractory Acute Graft-versus-host Disease
medac GmbH 210
Load More Results